Adenovirus vectors activate survival pathways in lung epithelial cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 287, Issue 2 31-2, 2004, Pages

  Flaherty, Dawn M ^a   Hinde, Sara L ^b   Monick, Martha M ^b   Powers, Linda S ^b   Bradford, Mary A ^b   Yarovinsky, Timur ^b   Hunninghake, Gary W ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b NONE

Author keywords

Akt; Apoptosis; Extracellular signal regulated kinase; Phosphatidylinositol 3 kinase

Indexed keywords

ADENOVIRUS VECTOR; DACTINOMYCIN; FAS LIGAND; GREEN FLUORESCENT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME ACTIVATION; ENZYME MECHANISM; EPITHELIUM CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SIGNAL TRANSDUCTION; TARGET CELL; TRANSGENE; ULTRAVIOLET RADIATION; VIRAL GENE THERAPY; VIRUS INFECTION; VIRUS REPLICATION;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADENOVIRIDAE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RESPIRATORY MUCOSA; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3242668092     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00359.2003     Document Type: Article

References (65)

1. Anderson RA, Boronenkov IV, Doughman SD, Kunz J, and Loijens JC. Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes. J Biol Chem 274: 9907-9910, 1999.
2. Anderson RD, Haskell RE, Xia H, Roessler BJ, and Davidson BL. A simple method for the rapid generation of recombinant adenovirus vectors. Gene Ther 7: 1034-1038, 2000.
3. Bhat NR and Fan F. Adenovirus infection induces microglial activation: involvement of mitogen-activated protein kinase pathways. Brain Res 948: 93-101, 2002.
4. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, and Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286: 1358-1362, 1999.
5. Bowen GP, Borgland SL, Lam M, Libermann TA, Wong NC, and Muruve DA. Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B. Hum Gene Ther 13: 367-379, 2002.
6. Bruder JT and Kovesdi I. Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J Virol 71: 398-404, 1997.
7. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, and Reed JC. Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321, 1998.
8. Dai Y, Schwarz EM, Gu D, Zhang WW, Sarvetnick N, and Verma IM. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 92: 1401-1405, 1995.
9. Dobner T, Horikoshi N, Rubenwolf S, and Shenk T. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272: 1470-1473, 1996.
10. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, and Greenberg ME. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665, 1997.
11. Engelhardt JF, Ye X, Doranz B, and Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 91: 6196-6200, 1994.
12. Erhardt P, Schremser EJ, and Cooper GM. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol Cell Biol 19: 5308-5315, 1999.
13. Eves EM, Xiong W, Bellacosa A, Kennedy SG, Tsichlis PN, Rosner MR, and Hay N. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol Cell Biol 18: 2143-2152, 1998.
14. Garrington TP and Johnson GL. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 11: 211-218, 1999.
15. Gutkind JS. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 273: 1839-1842, 1998.
16. Halbert DN, Cutt JR, and Shenk T. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J Virol 56: 250-257, 1985.
17. Han J, Sabbatini P, Perez D, Rao L, Modha D, and White E. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev 10: 461-477, 1996.
18. Hay RT, Freeman A, Leith I, Monaghan A, and Webster A. Molecular interactions during adenovirus DNA replication. Curr Top Microbiol Immunol 199: 31-48, 1995.
19. Higginbotham JN, Seth P, Blaese RM, and Ramsey WJ. The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants and capsid. Hum Gene Ther 13: 129-141, 2002.
20. Ilan Y, Droguett G, Chowdhury NR, Li Y, Sengupta K, Thummala NR, Davidson A, Chowdhury JR, and Horwitz MS. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc Natl Acad Sci USA 94: 2587-2592, 1997.
21. Jornot L, Petersen H, Lusky M, Pavirani A, Moix I, Morris, and Rochat T. Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death. Endothelium 8: 167-179, 2001.
22. Joseph TD and Look DC. Specific inhibition of interferon signal transduction pathways by adenoviral infection. J Biol Chem 276: 47136-47142, 2001.
23. Kafri T, Morgan D, Krahl T, Sarvetnick N, Sherman L, and Verma I. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc Natl Acad Sci USA 95: 11377-11382, 1998.
24. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, and Evan G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385: 544-548, 1997.
25. Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH, and Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 16: 2783-2793, 1997.
26. King WG, Mattaliano MD, Chan TO, Tsichlis PN, and Brugge JS. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol Cell Biol 17: 4406-4418, 1997.
27. Knowles MR, Hohneker KW, Zhou Z, Olsen JC, Noah TL, Hu PC, Leigh MW, Engelhardt JF, Edwards LJ, Jones KR, Grossman M, Wilson JM, Johnson LG, and Boucher RC. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 333: 823-831, 1995.
28. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, and Burgering BM. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398: 630-634, 1999.
29. Kulik G and Weber MJ. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol Cell Biol 18: 6711-6718, 1998.
30. Lazrak A, Samanta A, and Matalon S. Biophysical properties and molecular characterization of amiloride-sensitive sodium channels in A549 cells. Am J Physiol Lung Cell Mol Physiol 278: L848-L857, 2000.
31. Leppard KN. E4 gene function in adenovirus, adenovirus vector and adeno-associated virus infections. J Gen Virol 78: 2131-2138, 1997.
32. Li E, Stupack D, Bokoch GM, and Nemerow GR. Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases. J Virol 72: 8806-8812, 1998.
33. Li E, Stupack D, Klemke R, Cheresh DA, and Nemerow GR. Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase. J Virol 72: 2055-2061, 1998.
34. Li E, Stupack DG, Brown SL, Klemke R, Schlaepfer DD, and Nemerow GR. Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry. J Biol Chem 275: 14729-14735, 2000.
35. Liu Q and Muruve DA. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther 10: 935-940, 2003.
36. Lu Y, Parkyn L, Otterbein LE, Kureishi Y, Walsh K, Ray A, and Ray P. Activated Akt protects the lung from oxidant-induced injury and delays death of mice. J Exp Med 193: 545-549, 2001.
37. Lukashok SA, Tarassishin L, Li Y, and Horwitz MS. An adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis complexes with dynein and a small GTPase. J Virol 74: 4705-4709, 2000.
38. MacFarlane M, Merrison W, Dinsdale D, and Cohen GM. Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis. J Cell Biol 148: 1239-1254, 2000.
39. Maeyama T, Kuwano K, Kawasaki M, Kunitake R, Hagimoto N, Matsuba T, Yoshimi M, Inoshima I, Yoshida K, and Hara N. Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis. Eur Respir J 17: 180-189, 2001.
40. Maiti D, Bhattacharyya A, and Basu J. Lipoarabinomannan from Mycobacterium tuberculosis promotes macrophage survival by phosphorylating Bad through a phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem 276: 329-333, 2001.
41. Mastronarde JG, He B, Monick MM, Mukaida N, Matsushima K, and Hunninghake GW. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6. J Infect Dis 174: 262-267, 1996.
42. Moore M, Horikoshi N, and Shenk T. Oncogenic potential of the adenovirus E4orf6 protein. Proc Natl Acad Sci USA 93: 11295-11301, 1996.
43. Muruve DA, Barnes MJ, Stillman IE, and Libermann TA. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum Gene Ther 10: 965-976, 1999.
44. Nagata S. Apoptosis by death factor. Cell 88: 355-365, 1997.
45. Nicolis E, Tamanini A, Melotti P, Rolfini R, Berton G, Cassatella MA, Bout A, Pavirani A, and Cabrini G. ICAM-1 induction in respiratory cells exposed to a replication-deficient recombinant adenovirus in vitro and in vivo. Gene Ther 5: 131-136, 1998.,
46. Noah TL, Wortman IA, Hu PC, Leigh MW, and Boucher RC. Cytokine production by cultured human bronchial epithelial cells infected with a replication-deficient adenoviral gene transfer vector or wild-type adenovirus type 5. Am J Respir Cell Mol Biol 14: 417-424, 1996.
47. Ohi N, Tokunaga A, Tsunoda H, Nakano K, Haraguchi K, Oda K, Motoyama N, and Nakajima T. A novel adenovirus E1B19K-binding protein B5 inhibits apoptosis induced by Nip3 by forming a heterodimer through the C-terminal hydrophobic region. Cell Death Differ 6: 314-325, 1999.
48. Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, and Murcia JM. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 273: 33533-33539, 1998.
49. Quinlan MP. E1A 12S in the absence of E1B or other cooperating oncogenes enables cells to overcome apoptosis. Oncogene 8: 3289-3296, 1993.
50. Ramalingam R, Rafii S, Worgall S, Brough DE, and Crystal RG. E1(-)E4(+) adenoviral gene transfer vectors function as a "pro-life" signal to promote survival of primary human endothelial cells. Blood 93: 2936-2944, 1999.
51. Ramalingam R, Rafii S, Worgall S, Hackett NR, and Crystal RG. Induction of endogenous genes following infection of human endothelial cells with an E1(-) E4(+) adenovirus gene transfer vector. J Virol 73: 10183-10190, 1999.
52. Russell WC. Update on adenovirus and its vectors. J Gen Virol 81: 2573-2604, 2000.
53. Schaeffer HJ and Weber MJ. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 19: 2435-2444, 1999.
54. Tamanini A, Rolfini R, Nicolis E, Melotti P, and Cabrini G. MAP kinases and NF-kappaB collaborate to induce ICAM-1 gene expression in the early phase of adenovirus infection. Virology 307: 228-242, 2003.
55. Tashker JS, Olson M, and Kornbluth S. Post-cytochrome C protection from apoptosis conferred by a MAPK pathway in Xenopus egg extracts. Mol Biol Cell 13: 393-401, 2002.
56. Tibbles LA, Spurrell JC, Bowen GP, Liu Q, Lam M, Zaiss AK, Robbins SM, Hollenberg MD, Wickham TJ, and Muruve DA. Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10. J Virol 76: 1559-1568, 2002.
57. Tollefson AE, Hermiston TW, Lichtenstein DL, Colle CF, Tripp RA, Dimitrov T, Toth K, Wells CE, Doherty PC, and Wold WS. Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 392: 726-730, 1998.
58. Wang R, Alam G, Zagariya A, Gidea C, Pinillos H, Lalude O, Choudhary G, Oezatalay D, and Uhal BD. Apoptosis of lung epithelial cells in response to TNF-alpha requires angiotensin II generation de novo. J Cell Physiol 185: 253-259, 2000.
59. Watanabe N, Dickinson DA, Krzywanski DM, Iles KE, Zhang H, Venglarik CJ, and Forman HJ. A549 subclones demonstrate heterogeneity in toxicological sensitivity and antioxidant profile. Am J Physiol Lung Cell Mol Physiol 283: L726-L736, 2002.
60. Wold WS and Gooding LR. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184: 1-8, 1991.
61. Xia Z, Dickens M, Raingeaud J, Davis RJ, and Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995.
62. Yang Y, Ertl HC, and Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1: 433-442, 1994.
63. Yang Y, Li Q, Ertl HC, and Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 69: 2004-2015, 1995.
64. Yarovinsky TO, Powers LS, Butler NS, Bradford MA, Monick MM, and Hunninghake GW. Adenoviral infection decreases mortality from lipopolysaccharide-induced liver failure via induction of TNF-alpha tolerance. J Immunol 171: 2453-2460, 2003.
65. Zhang F, Cheng J, Hackett NR, Lam G, Shido K, Pergolizzi R, Jin DK, Crystal RG, and Rafii S. Adenovirus E4 gene promotes selective endothelial cell survival and angiogenesis via activation of the vascular endothelial-cadherin/ Akt signaling pathway. J Biol Chem 279: 11760-11766, 2004.